Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina
Departamento
Hospital Arnau de Vilanova
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Arnau de Vilanova (38)
2024
-
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Breast Cancer Research and Treatment
2023
-
Burden of refractory and unexplained chronic cough on patients’ lives: a cohort study
ERJ Open Research, Vol. 9, Núm. 5
2022
-
Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries
Frontiers in Cardiovascular Medicine, Vol. 9
-
National Survey: How Do We Approach the Patient at Risk of Clinical Deterioration outside the ICU in the Spanish Context?
International Journal of Environmental Research and Public Health, Vol. 19, Núm. 19
-
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
BMC Cardiovascular Disorders, Vol. 22, Núm. 1
2021
-
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Frontiers in Physiology, Vol. 12
-
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
npj Breast Cancer, Vol. 7, Núm. 1
-
Seaic specialty forum: Analysis of the current situation of allergology in spain and outlook for the future
Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 2, pp. 120-131
2020
-
A proposed approach to chronic airway disease (CAD) using therapeutic goals and treatable traits: A look to the future
International Journal of COPD, Vol. 15, pp. 2091-2100
-
Accuracy of right ventricular volume and function assessed with cardiovascular magnetic resonance: comparison with echocardiographic parameters
Clinical Imaging, Vol. 59, Núm. 1, pp. 61-67
-
Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure
REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164
-
Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial
Drugs in Context, Vol. 9
-
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition
Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706
-
Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial
Pleura and Peritoneum, Vol. 5, Núm. 1
2019
-
Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations
Pancreatology, Vol. 19, Núm. 4, pp. 488-499
-
CTCs-derived xenograft development in a triple negative breast cancer case
International Journal of Cancer, Vol. 144, Núm. 9, pp. 2254-2265
2018
-
Development and validation of a scoring system for the identification of pleural exudates of cardiac origin
European Journal of Internal Medicine, Vol. 50, pp. 60-64
2017
-
Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma
International Journal of Cancer, Vol. 140, Núm. 7, pp. 1551-1563
-
La fracción de eyección intermedia no permite estratificar el riesgo de los pacientes hospitalizados por insuficiencia cardiaca
Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 338-346
-
Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure
International Journal of Cardiology, Vol. 240, pp. 265-270